Suven Pharmaceuticals Limited
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Suven Pharmaceuticals Limited's balance sheet done over the years? Its assets were worth $22,540,865,000 last year, which is more than in the previous period. 9% of Suven Pharmaceuticals Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $2,034,230,000, which means an decrease by -33% compared compared to last year.

Debt to Assets

Suven Pharmaceuticals Limited (NSE:SUVENPHAR.NS): Debt to assets
2019 7830163000 1.92B 24.61%
2020 11728105000 3.28B 27.97%
2021 14744651000 2.93B 19.92%
2022 18295873000 3.02B 16.53%
2024 22540865000 2.03B 9.02%

SUVENPHAR.NS Balance Sheet (2018 – 2023)

2023 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
472.31M445.63M71.82M116.95M109.03M
Short term investments
7.73B4.81B1.80B306.76M70.63M
Net receivables
1.33B3.17B1.75B1.74B2.11B
Inventory
2.31B2.83B2.01B1.74B1.57B
Other current assets
758.13M14.56M153K-2K34.43M
Total current assets
12.63B11.27B5.64B3.91B3.89B
Non-current assets:
Property, Plant and Equipment
7.86B5.61B5.34B4.55B3.79B
Goodwill
602.58M0000
Intangible assets
16.67M22.36M25.90M27.96M26.85M
Long term investments
1.30B1.17B3.61B3.07B705K
Other non-current assets
116.16M-1K59.92M133.12M-3.82B
Total non-current assets
9.90B7.01B9.09B7.81B3.93B
Total assets
22.54B18.29B14.74B11.72B7.83B
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
1.58M340.70M278.54M309.65M159.69M
Short term debt
437.60M682.23M1.06B944.42M827.93M
Total current liabilities
1.06B2.10B2.19B2.00B1.57B
Non-current liabilities:
Long term debt
212.35M289.03M363.29M917.64M0
Deferred tax
00000
Other non-current liabilities
105.00M-284.40M-355.90M1K59.45M
Total non-current liabilities
965.27M921.12M739.08M1.27B351.17M
Total liabilities
2.03B3.02B2.93B3.28B1.92B
Data sourceData sourceData sourceData sourceData source